TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: GAO Reopens Clinical Center Controversy On Patient Care Payment; NIH Still Resists January 6, 1978
TCL Archive Senate committee approves Lester Crawford’s nomination for FDA Commissioner. June 17, 2005
